Maude was born and raised in Montreal. She recently graduated with a B.Sc. Physics and will pursue her M.Sc. Medical Physics at McGill University starting in Fall 2022. She joined the Enger Lab in November 2021.
169-Yb based high dose rate intensity modulated brachytherapy for focal treatment of prostate cancer
Maude is currently investigating intensity-modulated brachytherapy (IMBT) in the focal treatment of prostate cancer as well as the possibility to achieve less invasive IMBT treatment plans.